| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 23, 2025 | Oct 27, 2025 | X4 Pharmaceuticals, Inc | Chair | Buy | 95.0 | +86,206 | 29.74% | ✗ | $250K |
| Feb 27, 2015 | Mar 2, 2015 | Viracta Therapeutics, Inc. | EVP, Development & CMO | Sell | 91.3 | +10,729 | 84.33% | ✗ | $18.4K |
| Aug 27, 2014 | Aug 29, 2014 | Viracta Therapeutics, Inc. | EVP, Development & CMO | Sell | 23.8 | -2,554 | -16.72% | ✓ | $20.4K |